1971
DOI: 10.1007/bf00403565
|View full text |Cite
|
Sign up to set email alerts
|

Correlation between the experimental data from animal studies and therapeutical effects of antidepressant drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1977
1977
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…First, although cyclobenzaprine is structurally similar to amitriptyline (difference of one double bond), it is possibly less potent than other tricyclics [3]. In animal models, it also has some antiepileptic effects ,which is consistent with its possible antispastic effects [20].…”
Section: Discussionmentioning
confidence: 93%
“…First, although cyclobenzaprine is structurally similar to amitriptyline (difference of one double bond), it is possibly less potent than other tricyclics [3]. In animal models, it also has some antiepileptic effects ,which is consistent with its possible antispastic effects [20].…”
Section: Discussionmentioning
confidence: 93%
“…The value of this antimuscarinic property in combating depressive illness has been only partially unexplored (Blackwell et al, 1972), although in animal neuropharmacological tests this effect is not conspicuous (Spencer, 1965;1966). Benesova & Nahunek (1971) show that imipramine and its close analogues are able to potentiate the central (and peripheral) effects of NA and/or 5-HT, that this is their overwhelming pharmacological property, and seems to correlate with our current knowledge of the biochemical basis of depressive illness. The tricyclics do not stimulate NA and 5-HT receptors, nor do they release endogenous amines; at high doses they may even exert a postsynaptic receptor-blocking action, reminiscent of the neuroleptics.…”
Section: Imipramine and Related Tricyclic Membrane-pump Inhibitorsmentioning
confidence: 89%
“…The value of this antimuscarinic property in combating depressive illness has been only partially unexplored (Blackwell et al, 1972), although in animal neuropharmacological tests this effect is not conspicuous (Spencer, 1965;1966). Benesova & Nahunek (1971) (Mallion et al, 1972) and (Greenwood, 1975). Brief reports of its clinical pharmacological activity have been given by Kirby & Turner (1974), Bayliss & Duncan (1974) and Turner et al (1975).…”
Section: Imipramine and Related Tricyclic Membrane-pump Inhibitorsmentioning
confidence: 99%
“…It is a weak inhibitor of norepinephrine and serotonin reuptake. It was created as antidepressant but had more adverse effects and less antidepressant effects than other tricyclic antidepressants (TCAs) [2,3]. It is the most common prescribed muscle relaxant and accounts for 18% of all prescriptions written for chronic back pain [4].…”
Section: Introductionmentioning
confidence: 99%